Alychlo NV

PE/Buy-Out · Merelbeke (Belgium)

PE/Buy-Out

Series D

Growth Capital

Consumer

Sign up free to access full profile and submit your pitch.

About

Alychlo NV is a venture capital and private equity firm making directs and indirect investments. Within direct investments it specializes in Middle Market, Later Stage, Mature, Turnaround, Emerging Growth, Late Venture, PIPEs, Bridge Financing, Industry Consolidation, Recapitalizations, and Buyout and growth capital investments. Within indirect investments it specializes in Private Equity, Venture Capital Funds and Real Estate Funds. The firm also makes Secondary Investing - Portfolio Company Interests. The firm invests in a wide range of sectors, primarily healthcare sectors, such as life sciences, biotechnology, with a particular focus on oncology and Hotels, Restaurants and Leisure. The firm prefers to invest in Europe, especially in Belgium. The firm makes equity investment ranging between Euro 10 million ($ 11.24 million) to Euro 50 million ($ 56.19 million). It prefers to take a minority stake. It makes Personal Capital and Balance Sheet Investments. Alychlo NV was founded in 2008 and is based in Merelbeke, Belgium.

Investment Criteria